Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)
Blood Cells, Molecules, and Diseases · 2021-09 · 90 · 102587
DOI: 10.1016/j.bcmd.2021.102587 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood Cells, Molecules, and Diseases, 2021-09. Verfasst von Dirk Roos und 35 weiteren Autor:innen. Beteiligte Einrichtung: Sanquin Research, and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam, the Netherlands. Electronic address: d.roos@sanquin.nl. Hauptthemen laut MEDLINE: Mutation. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 137 Literaturangaben.
Abstract (Originalsprache)
Chronic granulomatous disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. CGD patients suffer from severe bacterial and fungal infections. The disease is caused by a lack of superoxide production by the leukocyte enzyme NADPH oxidase. Superoxide and subsequently formed other reactive oxygen species (ROS) are instrumental in killing phagocytosed micro-organisms in neutrophils, eosinophils, monocytes and macrophages. The leukocyte NADPH oxidase is composed of five subunits, of which the enzymatic component is gp91phox, also called Nox2. This protein is encoded by the CYBB gene on the X chromosome. Mutations in this gene are found in about 70% of all CGD patients in Europe and in about 20% in countries with a high ratio of parental consanguinity. This article lists all mutations identified in CYBB and should therefore help in genetic counseling of X-CGD patients' families. Moreover, apparently benign polymorphisms in CYBB are also given, which should facilitate the recognition of disease-causing mutations. In addition, we also include some mutations in G6PD, the gene on the X chromosome that encodes glucose-6-phosphate dehydrogenase, because inactivity of this enzyme may lead to shortage of NADPH and thus to insufficient activity of NADPH oxidase. Severe G6PD deficiency can induce CGD-like symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sanquin Research, and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam, the Netherlands. Electronic address: d.roos@sanquin.nl.
- Sanquin Research, and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.
- Neutrophil Monitoring Laboratory, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
- GeneDx, Gaithersburg, MD, USA.
- University Grenoble Alpes, CEA, CNRS, IBS, and Centre Hospitalier Universitaire Grenoble Alpes, Chronic Granulomatous Disease Diagnosis and Research Centre (CDiReC), 38000, Grenoble, France.
Zitieren
APA
Roos, D., van Leeuwen, K., Hsu, A. P., Priel, D. L., Begtrup, A., Brandon, R., Stasia, M. J., Bakri, F. G., Köker, N., Köker, M. Y., Madkaika, M., de Boer, M., Garcia-Morato, M. B., Shephard, J. L. V., Roesler, J., Kanegane, H., Kawai, T., Di Matteo, G., Shahrooei, M., …, & Kuhns, D. B. (2021). Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules, and Diseases, 90, 102587. https://doi.org/10.1016/j.bcmd.2021.102587
Vancouver
Roos D, van Leeuwen K, Hsu AP, Priel DL, Begtrup A, Brandon R, et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules, and Diseases. 2021;90:102587. doi:10.1016/j.bcmd.2021.102587
BibTeX
@article{Roos2021,
author = {Roos, Dirk and van Leeuwen, Karin and Hsu, Amy P and Priel, Debra Long and Begtrup, Amber and Brandon, Rhonda and Stasia, Marie José and Bakri, Faris Ghalib and Köker, Nezihe and Köker, M Yavuz and Madkaika, Manisha and de Boer, Martin and Garcia-Morato, Maria Bravo and Shephard, Juan Luis Valdivieso and Roesler, Joachim and Kanegane, Hirokazu and Kawai, Toshinao and Di Matteo, Gigliola and Shahrooei, Mohammad and Bustamante, Jacinta and Rawat, Amit and Vignesh, Pandiarajan and Mortaz, Esmaeil and Fayezi, Abbas and Cagdas, Deniz and Tezcan, Ilhan and Kitcharoensakkul, Maleewan and Dinauer, Mary C and Meyts, Isabelle and Wolach, Baruch and Condino-Neto, Antonio and Zerbe, Christa S and Holland, Steven M and Malech, Harry L and Gallin, John I and Kuhns, Douglas B},
title = {Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)},
journal = {Blood Cells, Molecules, and Diseases},
year = {2021},
volume = {90},
pages = {102587},
doi = {10.1016/j.bcmd.2021.102587}
}
EUVIMED